高强度聚焦超声消融治疗子宫肌瘤的疗效及安全性评估  

Effectiveness and Safety of High-Intensity Focused Ultrasound Ablation in the Treatment of Uterine Fibroids

作　　者：方燕飞[1] 李建平[1] 赵瑾[1] 

机构地区：[1]杭州市萧山区第一人民医院妇科,浙江 杭州

出　　处：《临床医学进展》2021年第3期1107-1111,共5页Advances in Clinical Medicine

摘　　要：目的:评估高强度聚焦超声消融治疗子宫肌瘤的有效性和安全性。方法:以我院2019年12月1日~2020年5月31日期间82例子宫肌瘤作为研究对象,评估高强度聚焦超声消融治疗的临床效果和安全性。结果:高强度聚焦超声消融治疗子宫肌瘤的消融率为84.89% + 14.44%。随访半年结果显示,患者的治疗总有效率达96.34%,治疗后经期延长、经量增多、贫血、痛经症状改善率达94.46%,不良反应率为4.87%。结论:高强度聚焦超声消融治疗子宫肌瘤是一种安全有效的无创治疗方式。Objective: To evaluate the effectiveness and safety of high-intensity focused ultrasound ablation in the treatment of uterine fibroids. Methods: The clinical effect and safety of high-intensity focused ultrasonic ablation therapy were evaluated with 82 cases of uterine fibroids from December 1, 2019 to May 31, 2020. Results: The ablation rate of high-intensity focused ultrasound ablation to treat uterine fibroids was 84.89% plus 14.44%. The six-month follow-up results showed that the total therapeutic efficiency of patients reached 96.34 percent, the rate of prolonged menstruation, increased menstruation, anemia, pain and symptoms improved by 94.46 percent, and the rate of adverse reactions was 4.87 percent. Conclusion: High-intensity focused ultrasound ablation treatment of uterine fibroids is a safe and effective noninvasive treatment.

关 键 词：高强度聚焦超声 子宫肌瘤 有效性 安全性 

分 类 号：R73[医药卫生—肿瘤]